Dr. Rosenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4501 X St
Suite 3016
Sacramento, CA 95817- Is this information wrong?
Education & Training
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2010
- Temple University HospitalResidency, Internal Medicine, 2007 - 2009
- Temple University HospitalInternship, Internal Medicine, 2006 - 2007
- Icahn School of Medicine at Mount SinaiClass of 2006
- Wesleyan UniversityBA, 1997 - 2001
Certifications & Licensure
- CA State Medical License 2014 - 2024
- MA State Medical License 2010 - 2015
- PA State Medical License 2006 - 2010
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2013 Dec 02
- Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma Start of enrollment: 2015 Oct 01
- AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2016 Jun 13
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsSurvival after diffuse large B-cell lymphoma among children, adolescents, and young adults in California, 2001-2014: A population-based study.Renata Abrahão, Raul C. Ribeiro, Daphne Y. Lichtensztajn, Aaron S. Rosenberg, Theresa H.M. Keegan> ;Pediatric Blood & Cancer. 2019 Apr 1
- 11 citationsAssociation Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma.Aaron S. Rosenberg, Ann Brunson, Brian A. Jonas, Theresa H.M. Keegan, Theodore Wun> ;Journal of the National Cancer Institute. 2019 Jan 1
- 3 citationsPlatelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopeniaTiffany K. Pon, Anjlee Mahajan, Aaron S. Rosenberg, Alpesh Amin, Digish Shah, Ian Jenkins, Vineet Gupta, Heather Hofmann, Anthony Bejjani, Richard H. White> ;Journal of Thrombosis and Thrombolysis. 2018 Mar 24
- Join now to see all
Journal Articles
- Association Between Autologous Stem Cell Transplant and Survival Among Californians with Multiple MyelomaAaron S Rosenberg, Brian A Jonas, Journal of the National Cancer Institute
Abstracts/Posters
- Blinatumomab/Lenalidomide in Relapsed/Refractory Non-HodgkinÍs Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative AnalysisAaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase I Study of Escalating Doses of Carfilzomib with Hyper-CVAD in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia/LymphomaAaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
- Member
Hospital Affiliations
- University of California, Davis Medical CenterSacramento, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: